↓ Skip to main content

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

Overview of attention for article published in Health and Quality of Life Outcomes, June 2012
Altmetric Badge

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
Published in
Health and Quality of Life Outcomes, June 2012
DOI 10.1186/1477-7525-10-66
Pubmed ID
Authors

Dennis A Revicki, Alfons JM van den Eertwegh, Paul Lorigan, Celeste Lebbe, Gerald Linette, Christian H Ottensmeier, Shima Safikhani, Marianne Messina, Axel Hoos, Samuel Wagner, Srividya Kotapati

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Netherlands 1 <1%
Unknown 110 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 13%
Student > Bachelor 14 13%
Other 12 11%
Researcher 11 10%
Student > Postgraduate 9 8%
Other 22 20%
Unknown 29 26%
Readers by discipline Count As %
Medicine and Dentistry 42 38%
Agricultural and Biological Sciences 11 10%
Nursing and Health Professions 10 9%
Psychology 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 5 4%
Unknown 33 29%